OrbiMed Capital GP VII LLC
CIK 1760648
Transactions on file
68
Open-market buys
28
Win rate (buys)
89%
28 scored
Avg % since filing (buys)
+66.9%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 2,000 | $16.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,700 | $174.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 16,000 | $131.8K | +7.3% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 4,000 | $33.0K | +7.3% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 39,600 | $310.9K | +12.6% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,816 | $77.1K | +12.6% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 125,200 | $915.2K | +20.9% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 30,891 | $225.8K | +20.9% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,000 | $141.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 5,000 | $35.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 37,100 | $288.6K | +13.6% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,267 | $72.1K | +13.6% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 98,600 | $777.0K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,400 | $192.3K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 97,800 | $766.8K | +12.8% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,313 | $190.6K | +12.8% | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -9.3% | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 507,119 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 625,743 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 616,984 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 642,745 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 196,541 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 588,235 | $10.00M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 61,516 | $1.05M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 256,448 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 513,067 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 1,333,975 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 7,127,019 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 300,249 | $5.10M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 564,187 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 769,601 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 2,000,962 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 10,690,530 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 758,279 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 333,333 | $5.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,703,314 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,087,934 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 2,002,310 | $0.00 | — | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 46,776 | $2.10M | +8.4% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 787,024 | $35.72M | +7.5% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 1,477 | $66.5K | +8.4% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 24,846 | $1.13M | +7.5% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 272,322 | $12.26M | +8.4% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 9,086 | $409.1K | +8.4% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 625,000 | $5.00M | +10.3% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 1,250,000 | $10.00M | +10.3% | open → |
| 2025-01-08 | 2025-01-08 | PASG Passage BIO, Inc. | 10% | Sale | 75,007 | $51.0K | +579.4% | open → |
| 2025-01-08 | 2025-01-07 | PASG Passage BIO, Inc. | 10% | Sale | 52,536 | $37.3K | +550.7% | open → |
| 2025-01-08 | 2025-01-06 | PASG Passage BIO, Inc. | 10% | Sale | 19,481 | $15.0K | +500.0% | open → |
| 2025-01-14 | 2025-01-14 | PASG Passage BIO, Inc. | 10% | Sale | 79,024 | $47.4K | +670.0% | open → |
| 2025-01-14 | 2025-01-10 | PASG Passage BIO, Inc. | 10% | Sale | 126,209 | $83.3K | +600.0% | open → |
| 2025-01-14 | 2025-01-13 | PASG Passage BIO, Inc. | 10% | Sale | 17,986 | $11.5K | +621.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +453.4% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +402.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +450.6% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +402.9% | open → |
| 2025-04-17 | 2025-04-17 | PASG Passage BIO, Inc. | 10% | Sale | 77,090 | $25.4K | +1300.0% | open → |
| 2025-04-17 | 2025-04-16 | PASG Passage BIO, Inc. | 10% | Sale | 61,638 | $20.3K | +1300.0% | open → |
| 2025-04-17 | 2025-04-15 | PASG Passage BIO, Inc. | 10% | Sale | 10,326 | $3.9K | +1115.8% | open → |
| 2025-04-24 | 2025-04-22 | PASG Passage BIO, Inc. | 10% | Sale | 78,049 | $26.5K | +1258.8% | open → |
| 2025-04-24 | 2025-04-23 | PASG Passage BIO, Inc. | 10% | Sale | 89,328 | $30.4K | +1258.8% | open → |
| 2025-04-24 | 2025-04-24 | PASG Passage BIO, Inc. | 10% | Sale | 68,195 | $21.8K | +1343.8% | open → |
| 2025-06-26 | 2025-06-25 | PASG Passage BIO, Inc. | 10% | Sale | 138,800 | $45.8K | +1300.0% | open → |
| 2025-06-26 | 2025-06-26 | PASG Passage BIO, Inc. | 10% | Sale | 213,257 | $70.4K | +1300.0% | open → |
| 2025-06-26 | 2025-06-24 | PASG Passage BIO, Inc. | 10% | Sale | 231,600 | $81.1K | +1220.0% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 74,465 | $1.32M | -37.0% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 140,057 | $2.49M | -37.0% | open → |
